TrialSite News reposts an exciting press release in Newswise from the University of Kansas. The University of Kansas has launched an innovative news community care program opening up clinical trial participation to potentially many more patients in the community. A new, first-of-its kind project from researchers at The University of Kansas Cancer Center aims to boost participation in urologic cancer clinical trials by partnering with community urologists.
Clinical trials are research studies that involve people. Clinical trials lead to new ways to prevent, detect or treat disease and are at the heart of all medical advances. Nearly all cancer treatments used today were studied and made available to patients through clinical trials. However, many people don’t take part because they are unaware of clinical trials or they have misconceptions about them.
That’s why KU Cancer Center launched Learn|Inform|Recruit, a program aimed at referring more patients to clinical trial opportunities. Led by principal investigator Shellie Ellis, PhD, a member of KU Cancer Center’s Cancer Control and Population Health research program, the Learn|Inform|Recruit program is initially focusing on urological cancers.
“We focused on a type of cancer that affects many so that our work would have the greatest impact,” Dr. Ellis said. “Approximately 326,000 people in the United States are diagnosed annually with a urological cancer. About 20 percent of all cancers are urologic, which includes cancer of the bladder, kidney, prostate and testicles.”
With funding from the Brown Family Foundation and fellowship training in implementation science from the National Cancer Institute, Learn|Inform|Recruit began by working with urologists and cancer care providers in Kansas to learn more about their unique practices. The program also developed ways to help them refer more of their patients to clinical trials when appropriate.
Key Research Contact:
Dr. Shellie Ellis, PhD